Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients

Background and Objectives: Graft-versus-host disease (GvHD) frequently complicates hematopoietic stem cell transplantation (HSCT). Emerging evidence suggests a correlation between gut microbiota and GvHD risk. This study aims to elucidate the microbiota profiles in HSCT patients before and after tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Pegah Panahi, Amir Hossein Hashemian, Mehrdad Payandeh, Mahdi Taghadosi, Bizhan Nomanpour
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2024-10-01
Series:Iranian Journal of Microbiology
Subjects:
Online Access:https://ijm.tums.ac.ir/index.php/ijm/article/view/4497
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850194283544444928
author Pegah Panahi
Amir Hossein Hashemian
Mehrdad Payandeh
Mahdi Taghadosi
Bizhan Nomanpour
author_facet Pegah Panahi
Amir Hossein Hashemian
Mehrdad Payandeh
Mahdi Taghadosi
Bizhan Nomanpour
author_sort Pegah Panahi
collection DOAJ
description Background and Objectives: Graft-versus-host disease (GvHD) frequently complicates hematopoietic stem cell transplantation (HSCT). Emerging evidence suggests a correlation between gut microbiota and GvHD risk. This study aims to elucidate the microbiota profiles in HSCT patients before and after transplantation and their association with GvHD. Materials and Methods: This study, conducted from December 2022 to December 2023, involved the collection of 15 stool samples from HSCT patients. Bacterial content was quantified using real-time PCR, while interleukin-6 levels were assessed via ELISA. Results: Among the 15 participants (8 male, 7 female), 9 underwent allogeneic HSCT (allo-HSCT) and 6 received autologous HSCT. In the aGvHD group, there was a significant reduction in the abundance of Bacteroides and Bifidobacterium compared to those without aGvHD. Additionally, declines were observed in Clostridium and Firmicutes populations. The genus Blautia also showed reduced prevalence in the aGvHD group, whereas no significant differences were noted in the uncomplicated group. ELISA analysis revealed that interleukin-6 levels remained within the normal range (30-960 pg/ml) with no significant elevation in the aGvHD group. Conclusion: The study highlights a notable association between alterations in gut microbiota, specifically reductions in certain bacterial populations and the development of aGvHD following allo-HSCT.
format Article
id doaj-art-8f694425f248494c9d7d23599cce20b4
institution OA Journals
issn 2008-3289
2008-4447
language English
publishDate 2024-10-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Microbiology
spelling doaj-art-8f694425f248494c9d7d23599cce20b42025-08-20T02:14:02ZengTehran University of Medical SciencesIranian Journal of Microbiology2008-32892008-44472024-10-0116510.18502/ijm.v16i5.16800Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patientsPegah Panahi0Amir Hossein Hashemian1Mehrdad Payandeh2Mahdi Taghadosi3Bizhan Nomanpour4Department of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran; Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranDepartment of Biostatistics, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranDepartment of Bone Marrow Transplantation, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah IranDepartment of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranDepartment of Microbiology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran Background and Objectives: Graft-versus-host disease (GvHD) frequently complicates hematopoietic stem cell transplantation (HSCT). Emerging evidence suggests a correlation between gut microbiota and GvHD risk. This study aims to elucidate the microbiota profiles in HSCT patients before and after transplantation and their association with GvHD. Materials and Methods: This study, conducted from December 2022 to December 2023, involved the collection of 15 stool samples from HSCT patients. Bacterial content was quantified using real-time PCR, while interleukin-6 levels were assessed via ELISA. Results: Among the 15 participants (8 male, 7 female), 9 underwent allogeneic HSCT (allo-HSCT) and 6 received autologous HSCT. In the aGvHD group, there was a significant reduction in the abundance of Bacteroides and Bifidobacterium compared to those without aGvHD. Additionally, declines were observed in Clostridium and Firmicutes populations. The genus Blautia also showed reduced prevalence in the aGvHD group, whereas no significant differences were noted in the uncomplicated group. ELISA analysis revealed that interleukin-6 levels remained within the normal range (30-960 pg/ml) with no significant elevation in the aGvHD group. Conclusion: The study highlights a notable association between alterations in gut microbiota, specifically reductions in certain bacterial populations and the development of aGvHD following allo-HSCT. https://ijm.tums.ac.ir/index.php/ijm/article/view/4497Gut microbiota;Hematopoietic stem cell transplantation;Graft-versus-host disease;Interleukin-6;Real-time polymerase chain reaction;Enzyme-linked immunosorbent assay
spellingShingle Pegah Panahi
Amir Hossein Hashemian
Mehrdad Payandeh
Mahdi Taghadosi
Bizhan Nomanpour
Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients
Iranian Journal of Microbiology
Gut microbiota;
Hematopoietic stem cell transplantation;
Graft-versus-host disease;
Interleukin-6;
Real-time polymerase chain reaction;
Enzyme-linked immunosorbent assay
title Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients
title_full Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients
title_fullStr Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients
title_full_unstemmed Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients
title_short Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients
title_sort gut microbiota and graft versus host disease in hematopoietic stem cell transplant patients
topic Gut microbiota;
Hematopoietic stem cell transplantation;
Graft-versus-host disease;
Interleukin-6;
Real-time polymerase chain reaction;
Enzyme-linked immunosorbent assay
url https://ijm.tums.ac.ir/index.php/ijm/article/view/4497
work_keys_str_mv AT pegahpanahi gutmicrobiotaandgraftversushostdiseaseinhematopoieticstemcelltransplantpatients
AT amirhosseinhashemian gutmicrobiotaandgraftversushostdiseaseinhematopoieticstemcelltransplantpatients
AT mehrdadpayandeh gutmicrobiotaandgraftversushostdiseaseinhematopoieticstemcelltransplantpatients
AT mahditaghadosi gutmicrobiotaandgraftversushostdiseaseinhematopoieticstemcelltransplantpatients
AT bizhannomanpour gutmicrobiotaandgraftversushostdiseaseinhematopoieticstemcelltransplantpatients